Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?

• CALLA (NCT03830866) is a randomized, international, double-blind, placebo-controlled study. • Immunotherapy-naïve patients with adenocarcinoma or cervical carcinoma are being enrolled. • CALLA is one of the largest trials in this patient population.

Detalles Bibliográficos
Autores principales: Monk, Bradley J., Mayadev, Jyoti, Nunes, Ana T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906726/
https://www.ncbi.nlm.nih.gov/pubmed/31867430
http://dx.doi.org/10.1016/j.gore.2019.100506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906726/
https://www.ncbi.nlm.nih.gov/pubmed/31867430
http://dx.doi.org/10.1016/j.gore.2019.100506

Ejemplares similares